+300x1002.png)
+480x1002.png)
AP- New research suggests the COVID-19 vaccine made by Pfizer and BioNTech can still work against a mutated coronavirus. Two easier-to-spread new variants of the virus have the world on edge. Two easier-to-spread new variants of the virus have the world on edge. Pfizer researchers say laboratory testing shows that the variants share a mutation that doesn’t block the vaccine. Meanwhile, in California, while facing a massive surge in coronavirus cases, the state has been issuing waivers allowing hospitals to temporarily bypass the nation’s only strict nurse-to-patient ratios. Nurses say that being forced to take on more patients is pushing them to the brink of burnout and affecting patient care.
Marco Bello / Reuters file
New research suggests the COVID-19 vaccine made by Pfizer and BioNTech can still work against a mutated coronavirus.
Posted: Jan 8, 2021 2:53 PM
Related Content
- Pfizer Says Vaccine Can Work Against Variants
- Pfizer Covid vaccine works against virus variants, new research suggests
- United Airlines To Fly Pfizer COVID-19 Vaccine
- AstraZeneca vaccine being tweaked to fight S. Africa variant
- How would COVID-19 vaccine makers adapt to variants?
- COVID-19 Vaccine is Looking 90% Effective According to Pfizer
- Pfizer Seeking Emergency Use of its COVID-19 Vaccine in US
- UK Authorizes Pfizer Coronavirus Vaccine for Emergency Use
- U.K. Becomes First Country to Approve Pfizer-BioNTech Covid-19 Vaccine
- U.K. Probing if Allergic Reactions Linked to Pfizer Vaccine
Scroll for more content...
.jpg)
